TrialThe Journal of urology2024

Impact of Divergent Differentiation and/or Histological Subtype of Urothelial Carcinoma on Patient Outcomes in the GETUG-AFU V05 VESPER Trial.

Yves Allory et al.PubMed ↗Publisher ↗

No numbers read from the abstract.